Newsletter Brand Institute is proud to have partnered with Pfizer and BioNTech on the brand and nonproprietary (INN) name development for COMIRNATY® (tozinameran)! The first vaccine approved for the prevention of coronavirus disease 2019 (COVID-19)BrandinstituteDecember 23, 2020
Newsletter Brand Institute is proud to have partnered with 850 healthcare companies on over 3,100 names, including eighteen (18) COVID-19 products and product candidates to date! Abbott’s molecular diagnostic platform that can test for the coronavirus (COVID-19)...BrandinstituteJune 1, 2020